Abstract:AIM: There are no studies on the correlation of T cells expressing CD94 to acute/chronic graft versus host disease after umbilical cord blood transplantation. OBJECTIVE: To determinate the effect of CD94 molecule on T lymphocyte in immune tolerance after umbilical cord blood transplantation. DESIGN: Case-control analysis. PARTICIPANTS: Fourteen children aged 2-9 years, averagely 6.8 years, undergoing umbilical cord blood transplantation were enrolled at the Center of Hematopoietic Stem Cell Transplantation, Second Affiliated Hospital, Sun Yat-sen University from January 1999 to June 2007. Nine children received HLA compatible transplantation, and five received unrelated donor transplantation. Simultaneously, peripheral blood samples of 34 children, who were normal after body examination, were used as controls, which were obtained from the Department of Pediatrics, Second Affiliated Hospital, Sun Yat-sen University, including 18 males and 15 females, averagely 4.5 years in age. METHODS: 2 mL of peripheral vein blood was collected from each normal child. 2 mL of peripheral vein blood was collected from each child patient following their absolute number of neutrophilic granulocytes was ≥0.5×109 L-1 after umbilical cord blood transplantation. Blood samples were placed in EDTA-2Na anticoagulation tube for measuring cell surface antigen. The measurement was performed once every 1-3 month until the end of the follow-up. All samples were subjected to standardization within 6 hours using double color and three color immunofluorescent staining. Flow cytometry was used to detect the CD94 expression on the T cell surface in the peripheral blood. MAIN OUTCOME MEASURES: Occurrence of graft versus host disease following umbilical cord blood transplantation; Correlation of graft versus host disease to CD94 expression on the T cell surface in the peripheral blood. RESULTS: Six cases undergoing compatible related umbilical cord blood transplantation had no acute graft versus host disease, but others developed acute graft versus host disease at 6-50 days after transplantation. Five cases developed chronic graft versus host disease. Compared with the normal controls, expression of CD3+CD4+CD94+ T cells and CD3+CD8+CD94+T cells significantly increased (P < 0.05). Compared with patients who did not develop acute graft versus host disease, the expression of CD3+CD4+CD94+ T cells and CD3+CD8+CD94+ T cells in patients with acute/chronic graft versus host disease significantly increased (P < 0.05). CONCLUSION: The patients after umbilical cord blood transplantation with acute graft versus host disease expressed CD94 on T lymphocytes in a high level, which suggested that the activation of CD94 molecule on T lymphocyte takes part in the development of graft versus host disease.

Significance of the expressions of CD40 and CD40 ligand to graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Expression of CD62L on Donor CD4 + T Cells in Allografts: Correlation with Graft-Versus-Host Disease after Unmanipulated Allogeneic Blood and Marrow Transplantation

Relationship between CD4+CD25+regulatory T cells and graft-versus-host disease after allogeneic haematogenesis stem cell transplantation

Association Between CD34+ and CD3+ T-cells in Allogeneic Grafts and Acute Graft-Versus-host Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study.

Effect of Costimulatory Moleculars on Graft-Versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Soluble Human Leukocyte Antigen G Molecule Expression In Allogeneic Hematopoietic Stem Cell Transplantation: Good Predictor Of Acute Graft-Versus-Host Disease

Cytokine expressions in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Correlation of graft versus host disease to CD94 molecule on T lymphocytes following umbilical cord blood transplantation

The CD4+CD25highregulatory T Cell Reconstitution after Allogenetic Stem Cell Transplantation and Its Correlations with aGVHD

[Effect of Graft-Versus-host Disease on Relapse and Survival in 100 Patients after Allogeneic Hematopoietic Stem Cell Transplantation].

Decrease of Cd4(+)Cd25(+) Regulatory T Cells and Tgf-Beta at Early Immune Reconstitution is Associated to the Onset and Severity of Graft-Versus-Host Disease Following Allogeneic Haematogenesis Stem Cell Transplantation

The Expression of Natural Killer Cells Inhibitory Receptors on Natural Killer Cells and T Lymphocytes and the Relationship with Acute Graft-Versus-host Disease

Gene Expression of Cytokines after Allogeneic Peripheral Stem Cell Transplantation and Its Relationship with Acute Graft-Versus-host Disease

[Influence of Graft-Versus-host Disease on Long-Term Survival of 26 Patients with Hematologic Malignancies after Transplantation].

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood regulatory T cells

Correlation of the CD4+CD25high T-regulatory Cells in Recipients and Their Corresponding Donors to Acute GVHD.

Expression of Killer Cell Inhibitor Receptors on Immunocompetent Cells with Relation to Graft-Versus-host Disease after Hematopoietic Stem Cell Transplantation.

Clinical Study of Chronic Graft-Versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Analysis on Graft-Versus-host Disease in 55 Cases of Allogeneic Hematopoietic Stem Cell Transplantation

The Effect of Donor Cd4(+)Cd25(+) Regulatory T Cells on Hematopoietic and Immune Reconstitution, Gvhd and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation.